Evidence map›Paper›PMID 36685500›Full record

ArticleFrontiers in immunology2022

Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis.

Arjan Boltjes, Anoushka Ashok Kumar Samat, Maud Plantinga, Michal Mokry, Bas Castelijns, Joost F Swart, Sebastiaan J Vastert, Menno Creyghton, Stefan Nierkens, Jorg van Loosdregt and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Reduced Expression of mInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Arjan BoltjesCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Anoushka Ashok Kumar SamatCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Maud PlantingaCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Michal MokryCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Bas CastelijnsHubrecht Institute, Utrecht, Netherlands.
Joost F SwartDepartment of Pediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Sebastiaan J VastertCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Menno CreyghtonHubrecht Institute, Utrecht, Netherlands.
Stefan NierkensCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Jorg van LoosdregtCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
Femke van WijkCenter for Translational Immunology, University Medical Center Utrecht (UMC Utrecht), Utrecht, Netherlands.
University Medical Center Utrecht · NLErasmus MC · NLHubrecht Institute for Developmental Biology and Stem Cell Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Dendritic cells (DC) are crucial for initiating and shaping immune responses. So far, little is known about the functional specialization of human DC subsets in (local) inflammatory conditions. We profiled conventional (c)DC1, cDC2 and monocytes based on phenotype, transcriptome and function from a local inflammatory site, namely synovial fluid (SF) from patients suffering from a chronic inflammatory condition, Juvenile Idiopathic Arthritis (JIA) as well as patients with rheumatoid arthritis (RA). Methods: Paired PB and SF samples from 32 JIA and 4 RA patients were collected for mononuclear cell isolation. Flow cytometry was done for definition of antigen presenting cell (APC) subsets. Cell sorting was done on the FACSAria II or III. RNA sequencing was done on SF APC subsets. Proliferation assays were done on co-cultures after CD3 magnetic activated cell sorting (MACS). APC Toll-like receptor (TLR) stimulation was done using Pam3CSK4, Poly(I:C), LPS, CpG-A and R848. Cytokine production was measured by Luminex. Results: cDC1, a relatively small DC subset in blood, are strongly enriched in SF, and showed a quiescent immune signature without a clear inflammatory profile, low expression of pathogen recognition receptors (PRRs), chemokine and cytokine receptors, and poor induction of T cell proliferation and cytokine production, but selective production of IFNλ upon polyinosinic:polycytidylic acid exposure. In stark contrast, cDC2 and monocytes from the same environment, showed a pro-inflammatory transcriptional profile, high levels of (spontaneous) pro-inflammatory cytokine production, and strong induction of T cell proliferation and cytokine production, including IL-17. Although the cDC2 and monocytes showed an overlapping transcriptional core profile, there were clear differences in the transcriptional landscape and functional features, indicating that these cell types retain their lineage identity in chronic inflammatory conditions. Discussion: Our findings suggest that at the site of inflammation, there is specific functional programming of human DCs, especially cDC2. In contrast, the enriched cDC1 remain relatively quiescent and seemingly unchanged under inflammatory conditions, pointing to a potentially more regulatory role.

Indexed as

Arthritis, JuvenileArthritis, RheumatoidCytokinesDendritic CellsHumansSynovial FluidCytokinesDC quiescenceDC subsetsfunctional programminginflammationjuvenile arthritissynovial fluid

Identifiers

PMID36685500
PMCPMC9846246
OpenAlexW4313584220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.